Aniracetam

DB04599InvestigationalSmall molecule

Aniracetam is a nootropic drug used to ameliorate memory and attention disturbances accompanying cerebrovascular diseases and degenerative brain disorders. Compound with anti-depressive properties used as a mental performance enhancer.

Chemical structure of Aniracetam
Mechanism
Curator reviewed
Formula / weight
C12H13NO3 · 219.2365 g/mol (avg)
Code names
RO 13-5057

Resolves to

Compound
UNII5L16LKN964CAS72432-10-1ChEMBLCHEMBL36994ChEBI47943PubChem2196KEGGD01883
Clinical / RWD
RxNorm17939ATCN06BX11
Structure
InChIKeyZXNRTKGTQJPIJK-UHFFFAOYSA-NSMILESCOC1=CC=C(C=C1)C(=O)N1CCCC1=O
Targets
P14416DRD2P28223HTR2AP42262GRIA2P42263GRIA3

What you can answer from here — as of September 13, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
680Drug interactionsStructured to mechanism, not free text
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
4Marketed productsAcross 1 country and 2 labellers
Sign in
1ATC codeIncluding every combination product, plus 9 drug categories
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Aniracetam, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In